These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 12811366)
1. A pharmacogenetic study of uridine diphosphate-glucuronosyltransferase 2B7 in patients receiving morphine. Sawyer MB; Innocenti F; Das S; Cheng C; Ramírez J; Pantle-Fisher FH; Wright C; Badner J; Pei D; Boyett JM; Cook E; Ratain MJ Clin Pharmacol Ther; 2003 Jun; 73(6):566-74. PubMed ID: 12811366 [TBL] [Abstract][Full Text] [Related]
2. Morphine glucuronide-to-morphine plasma ratios are unaffected by the UGT2B7 H268Y and UGT1A1*28 polymorphisms in cancer patients on chronic morphine therapy. Holthe M; Klepstad P; Zahlsen K; Borchgrevink PC; Hagen L; Dale O; Kaasa S; Krokan HE; Skorpen F Eur J Clin Pharmacol; 2002 Aug; 58(5):353-6. PubMed ID: 12185559 [TBL] [Abstract][Full Text] [Related]
3. A novel functional polymorphism in the uridine diphosphate-glucuronosyltransferase 2B7 promoter with significant impact on promoter activity. Duguay Y; Báár C; Skorpen F; Guillemette C Clin Pharmacol Ther; 2004 Mar; 75(3):223-33. PubMed ID: 15001974 [TBL] [Abstract][Full Text] [Related]
4. Morphine clearance in children: does race or genetics matter? Sadhasivam S; Krekels EH; Chidambaran V; Esslinger HR; Ngamprasertwong P; Zhang K; Fukuda T; Vinks AA J Opioid Manag; 2012; 8(4):217-26. PubMed ID: 22941849 [TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor involved epigenetic repression of UGT2B7 in colorectal carcinoma: A mechanism to alter morphine glucuronidation in tumor. Yang ZZ; Li L; Xu MC; Ju HX; Hao M; Gu JK; Jim Wang ZJ; Jiang HD; Yu LS; Zeng S Oncotarget; 2017 Apr; 8(17):29138-29150. PubMed ID: 28418861 [TBL] [Abstract][Full Text] [Related]
7. The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variants. Yang ZZ; Li L; Wang L; Yuan LM; Xu MC; Gu JK; Jiang HD; Yu LS; Zeng S Acta Pharmacol Sin; 2017 Aug; 38(8):1184-1194. PubMed ID: 28552915 [TBL] [Abstract][Full Text] [Related]
8. Sequence variations in the UDP-glucuronosyltransferase 2B7 (UGT2B7) gene: identification of 10 novel single nucleotide polymorphisms (SNPs) and analysis of their relevance to morphine glucuronidation in cancer patients. Holthe M; Rakvåg TN; Klepstad P; Idle JR; Kaasa S; Krokan HE; Skorpen F Pharmacogenomics J; 2003; 3(1):17-26. PubMed ID: 12629580 [TBL] [Abstract][Full Text] [Related]
9. Sequence variability and candidate gene analysis in two cancer patients with complex clinical outcomes during morphine therapy. Hirota T; Ieiri I; Takane H; Sano H; Kawamoto K; Aono H; Yamasaki A; Takeuchi H; Masada M; Shimizu E; Higuchi S; Otsubo K Drug Metab Dispos; 2003 May; 31(5):677-80. PubMed ID: 12695358 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomics of codeine, morphine, and morphine-6-glucuronide: model-based analysis of the influence of CYP2D6 activity, UGT2B7 activity, renal impairment, and CYP3A4 inhibition. Eissing T; Lippert J; Willmann S Mol Diagn Ther; 2012 Feb; 16(1):43-53. PubMed ID: 22352453 [TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetics of morphine and its glucuronide conjugate in a rat model of streptozotocin-induced diabetes and the expression of MRP2, MRP3 and UGT2B1 in the liver. Hasegawa Y; Kishimoto S; Shibatani N; Nomura H; Ishii Y; Onishi M; Inotsume N; Takeuchi Y; Fukushima S J Pharm Pharmacol; 2010 Mar; 62(3):310-4. PubMed ID: 20487213 [TBL] [Abstract][Full Text] [Related]
12. Influence of UGT2B7, OPRM1 and ABCB1 gene polymorphisms on postoperative morphine consumption. Bastami S; Gupta A; Zackrisson AL; Ahlner J; Osman A; Uppugunduri S Basic Clin Pharmacol Toxicol; 2014 Nov; 115(5):423-31. PubMed ID: 24703092 [TBL] [Abstract][Full Text] [Related]
13. CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients. Kwara A; Lartey M; Sagoe KW; Kenu E; Court MH AIDS; 2009 Oct; 23(16):2101-6. PubMed ID: 19779319 [TBL] [Abstract][Full Text] [Related]
14. Single nucleotide polymorphism discovery and functional assessment of variation in the UDP-glucuronosyltransferase 2B7 gene. Innocenti F; Liu W; Fackenthal D; Ramírez J; Chen P; Ye X; Wu X; Zhang W; Mirkov S; Das S; Cook E; Ratain MJ Pharmacogenet Genomics; 2008 Aug; 18(8):683-97. PubMed ID: 18622261 [TBL] [Abstract][Full Text] [Related]
15. Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer. Fujita K; Ando Y; Yamamoto W; Miya T; Endo H; Sunakawa Y; Araki K; Kodama K; Nagashima F; Ichikawa W; Narabayashi M; Akiyama Y; Kawara K; Shiomi M; Ogata H; Iwasa H; Okazaki Y; Hirose T; Sasaki Y Cancer Chemother Pharmacol; 2010 Jan; 65(2):251-8. PubMed ID: 19466410 [TBL] [Abstract][Full Text] [Related]
16. Effects of UGT2B7 Genetic Polymorphisms on Serum Concentrations of Valproic Acid in Chinese Children With Epilepsy Comedicated With Lamotrigine. Wang Q; Zhao L; Liang M; Dong Y; Yun W; Qiu F; Meng H; Guo Y Ther Drug Monit; 2016 Jun; 38(3):343-9. PubMed ID: 26717295 [TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics and Morphine. Ofoegbu A; B Ettienne E J Clin Pharmacol; 2021 Sep; 61(9):1149-1155. PubMed ID: 33847389 [TBL] [Abstract][Full Text] [Related]
18. Epirubicin glucuronidation is catalyzed by human UDP-glucuronosyltransferase 2B7. Innocenti F; Iyer L; Ramírez J; Green MD; Ratain MJ Drug Metab Dispos; 2001 May; 29(5):686-92. PubMed ID: 11302935 [TBL] [Abstract][Full Text] [Related]
19. Morphine Dose Optimization in Critically Ill Pediatric Patients With Acute Respiratory Failure: A Population Pharmacokinetic-Pharmacogenomic Study. Zuppa AF; Benitez GR; Zane NR; Curley MAQ; Bradfield J; Hakonarson H; Gastonguay MS; Moorthy G; Prodell J; Gastonguay MR Crit Care Med; 2019 Jun; 47(6):e485-e494. PubMed ID: 30920410 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of UDP-glucuronosyltransferase 2b7-catalyzed morphine glucuronidation by ketoconazole: dual mechanisms involving a novel noncompetitive mode. Takeda S; Kitajima Y; Ishii Y; Nishimura Y; Mackenzie PI; Oguri K; Yamada H Drug Metab Dispos; 2006 Aug; 34(8):1277-82. PubMed ID: 16679387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]